Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Veklury Gets EMA All-Clear Over Kidney Problems, But Faces New Safety Review For Bradycardia
Obesity Medicine Amfepramone Also Under The Safety Spotlight
Feb 15 2021
•
By
Vibha Sharma
EU regulators are monitoring the safety of Veklury in COVID-19 patients • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Drug Safety
More from Pink Sheet